Article


COVID-19 War, Blood Cells Disorder Paradoxically Increase Death Rates

Bahram Alamdary Badlou

Hematologist, BBAdvies and Research, Research and Development Dept., Zeist, The Netherlands

Dr. Bahram Alamdary Badlou, Hematologist, BBAdvies and Research, Research and Development Dept., Zeist, The Netherlands.

Keywords: Platelets; Policy; Human

Abstract

The COVID-19 pandemic infection increased the death rate by more than 6.2 million deaths, and almost 500 million reported (un-)known infected subjects, globally, and counting (April 2022). Remarkable is, on one hand, the coronavirus is almost known for Centuries and could not kill so many subjects in the last decades. On the other hand, a small mutation in S- and N-sections could well infect and kill unknown subject(s) that simply is not still elucidated which exact mechanism using COVID-19 mutants and novel variants to kill patients [1-7].
Introduced naïve guidelines and algorithms to tackle COVID-19variants were unsuccessful, and obviously based on “lack of knowledge”, inconsistently new policies are dictating people to follow new instructions.

View Full Text | Download PDF

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Total Articles Published

8
9
2


Total Citations:

1
8
4




Highlights


Cient Periodique is a ‘Gold’ open access publisher that aspires to offer absolute free, unrestricted access to the valuable research information

We welcome all the eminent authors to submit your valuable paper

Cient Periodique invites the participation of honourable Editors and Authors

CPQ Journals provide Certificates for publication

Cient Periodique also offers memberships for potential Authors

Best Articles will be appreciated with the provision of corresponding Certificate

Hi!

We're here to answer your questions!


Send us a message via Whatsapp, and we'll reply the moment we're available!